Fukuizumi et al., 1997 - Google Patents
Tonsillar application of killed Streptococcus mutans induces specific antibodies in rabbit saliva and blood plasma without inducing a cross-reacting antibody to human …Fukuizumi et al., 1997
View PDF- Document ID
- 9543627882042327623
- Author
- Fukuizumi T
- Inoue H
- Tsujisawa T
- Uchiyama C
- Publication year
- Publication venue
- Infection and immunity
External Links
Snippet
When Streptococcus mutans cells are injected into the skeletal muscle of rabbits, an antibody against human cardiac muscle, as well as an anti-S. mutans antibody, is induced in blood plasma. Our previous study showed that when sheep erythrocytes are applied to …
- 241000194019 Streptococcus mutans 0 title abstract description 106
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay
- G01N33/569—Immunoassay; Biospecific binding assay for micro-organisms, e.g. protozoa, bacteria, viruses
- G01N33/56911—Bacteria
- G01N33/5695—Mycobacteria
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/12—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria
- C07K16/1203—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-negative bacteria
- C07K16/1228—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-negative bacteria from Enterobacteriaceae (F), e.g. Citrobacter, Serratia, Proteus, Providencia, Morganella, Yersinia
- C07K16/1232—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-negative bacteria from Enterobacteriaceae (F), e.g. Citrobacter, Serratia, Proteus, Providencia, Morganella, Yersinia from Escherichia (G)
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/12—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria
- C07K16/1267—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-positive bacteria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Estein et al. | The recombinant Omp31 from Brucella melitensis alone or associated with rough lipopolysaccharide induces protection against Brucella ovis infection in BALB/c mice | |
Ebersole et al. | Human immune responses to oral microorganisms. II. Serum antibody responses to antigens from Actinobacillus actinomycetemcomitans and the correlation with localized juvenile periodontitis | |
Shaniztki et al. | Identification of a Fusobacterium nucleatum PK1594 galactose-binding adhesin which mediates coaggregation with periopathogenic bacteria and hemagglutination | |
AU681043B2 (en) | Diagnostic testing for campylobacter jejuni or coli infection using antigens | |
Mouton et al. | Immunochemical identification and preliminary characterization of a nonfimbrial hemagglutinating adhesin of Bacteroides gingivalis | |
Tikkanen et al. | The galactosyl-(alpha 1-4)-galactose-binding adhesin of Streptococcus suis: occurrence in strains of different hemagglutination activities and induction of opsonic antibodies | |
Olive et al. | Protection of mice from group A streptococcal infection by intranasal immunisation with a peptide vaccine that contains a conserved M protein B cell epitope and lacks a T cell autoepitope | |
Bammann et al. | Immunoglobulin A antibodies reactive with Streptococcus mutans in saliva of adults, children, and predentate infants | |
US5474905A (en) | Antibodies specific for streptococcus pneumoniae hemin/hemoglobin-binding antigens | |
Cunningham et al. | Murine monoclonal antibodies reactive with human heart and group A streptococcal membrane antigens | |
JP3124753B2 (en) | Influenza vaccine and diagnostic methods | |
Gmür et al. | Production and characterization of monoclonal antibodies specific for Bacteroides gingivalis | |
Sørensen et al. | Phosphorylcholine determinants in six pneumococcal capsular polysaccharides detected by monoclonal antibody | |
Smith et al. | Characterization of monoclonal antibodies to Streptococcus mutans antigenic determinants I/II, I, II, and III and their serotype specificities | |
Pedersen et al. | Anti‐C‐carbohydrate antibodies after pneumococcal vaccination | |
Fukuizumi et al. | Tonsillar application of killed Streptococcus mutans induces specific antibodies in rabbit saliva and blood plasma without inducing a cross-reacting antibody to human cardiac muscle | |
Brady et al. | Monoclonal antibody-mediated modulation of the humoral immune response against mucosally applied Streptococcus mutans | |
Moore et al. | Antigenic analysis of fimbrial proteins from Moraxella bovis | |
Lamont et al. | Streptococcus sanguis surface antigens and their interactions with saliva | |
Harrington et al. | Multiple changes in cell wall antigens of isogenic mutants of Streptococcus mutans | |
McGhee et al. | Induction of secretory antibodies in humans following ingestion of Streptococcus mutans | |
Hamada et al. | Serotype‐dependent inhibition of glucan synthesis and cell adherence of Streptococcus mutans by antibody against glucosyltransferase of serotype e S. mutans | |
De Soet et al. | Identification of mutans streptococci with monoclonal antibodies | |
Russell et al. | Immunization of monkeys (Macaca fascicularis) with purified Streptococcus mutans glucosyltransferase | |
Wunder et al. | Effects of antibodies to glucosyltransferase on soluble and insolubilized enzymes |